Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
60 years of DTB
Latest content
Current issue
Archive
Browse
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
60 years of DTB
Latest content
Current issue
Archive
Browse
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 61, Issue 3
Evidence for lecanemab in early Alzheimer’s disease
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
DTB select
Evidence for lecanemab in early Alzheimer’s disease
Online download statistics by month:
Online download statistics by month: February 2023 to February 2023
Abstract
Full
Pdf
Feb 2023
2035
66
35
Total
2035
66
35
Read the full text or download the PDF:
Subscribe (£100)
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF